Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Mar. 31, 2025
Current assets    
Cash, cash equivalents, and restricted cash $ 37,960 $ 40,084
Accounts receivable, net 251,240 181,770
Prepaid expenses 6,060 6,923
Value-added tax receivable 4,461 8,291
Other current assets 12,149 5,711
Total current assets 311,870 242,779
Property and equipment, net 49,111 46,966
Right-of-use assets 7,739 9,924
Intangible assets, net 217,448 257,697
Goodwill 223,053 221,741
Other non-current assets 32,433 33,747
TOTAL ASSETS 841,654 812,854
Current liabilities    
Accounts payable 132,807 139,944
Accrued revenue share 87,215 35,264
Accrued compensation 22,408 7,503
Acquisition purchase price liabilities 436 1,697
Current portion of long-term debt 7,031 0
Other current liabilities 18,402 38,118
Total current liabilities 268,299 222,526
Long-term debt, net 353,932 408,687
Derivative liabilities 2,164 0
Deferred tax liabilities, net 15,818 16,308
Other non-current liabilities 9,280 11,375
Total liabilities 649,493 658,896
Commitments and contingencies (Note 17)
Stockholders’ equity    
Preferred stock 100 100
Common stock 10 10
Additional paid-in capital 969,062 892,665
Treasury stock (758,125 shares at March 31, 2026, and March 31, 2025) (71) (71)
Accumulated other comprehensive loss (51,766) (51,304)
Accumulated deficit (725,174) (687,442)
Total stockholders’ equity 192,161 153,958
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 841,654 $ 812,854